Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
about
Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in TanzaniaPlasmodium falciparum drug resistance in AngolaEfficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in SudanSpread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.Genetic Analysis and Species Specific Amplification of the Artemisinin Resistance-Associated Kelch Propeller Domain in P. falciparum and P. vivaxRobust Algorithm for Systematic Classification of Malaria Late Treatment Failures as Recrudescence or Reinfection Using Microsatellite Genotyping.In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine SensitivityAssessment of pharmacokinetic compatibility of short acting CDRI candidate trioxane derivative, 99-411, with long acting prescription antimalarials, lumefantrine and piperaquine.Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, AngolaIn vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015.Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites.Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia.pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies.Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.Reply to "no robust evidence of lumefantrine resistance".No robust evidence of lumefantrine resistance.Interpreting Data from Passive Surveillance of Antimalarial Treatment Failures.A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the anti-malarial agents KAF156 and piperaquine.Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015.Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum.Efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in NepalPlasmodium falciparum Plasmepsin 2 Duplications, West AfricaHigh efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, TanzaniaEfficacy of artemisinin-based combination therapies and prevalence of molecular markers associated with artemisinin, piperaquine and sulfadoxine-pyrimethamine resistance in Sierra LeonePrevalence of antimalarial drug resistance genes in Southeastern Gabon from 2011 to 2014Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
P2860
Q26820807-0C5F0587-10E4-4E19-BC13-EA2CE5A4A67BQ28075079-B21EEB4A-5CD0-4013-8A35-5948C552EBFFQ33587604-C71032D8-CBB0-41C5-950F-B05EB55AE7A6Q35217991-5FD179ED-1251-49CE-B581-F4C45DA22695Q35751430-2248AA8E-620E-4D39-B16A-94E872210756Q36075776-12169353-EBB7-429D-B692-2C1062192A76Q36290734-E204FFF5-6A20-4873-BD44-393CFE1FD7DEQ36316695-B6E4629C-8C2E-44C4-9A3C-AAFABB5505E4Q36376796-CF642F5A-92A5-4CD1-BE5C-4BF1AB498C31Q36836576-F9DE7F24-D5E0-4056-82E9-DF06BE3A57F8Q37623024-CCEC6E6C-1135-418A-B95E-37F8CBCF6A05Q38624931-F7420E45-11FD-497D-8F40-A46678791180Q39025693-151ACC23-0F0B-40DA-B479-460151647E12Q39206934-E0A94697-BDB8-42EA-B68D-D0DF848D8F3CQ40106428-B5A8D3FD-0ABA-4EDC-A33E-B0DAE004E31FQ42545563-24AC10CC-2272-4244-8FB3-DE2BD8B64736Q42546115-C0588D21-49E2-4E8B-9E13-8987DBB0C9EAQ45199456-26707DEE-4E92-40BC-A63C-2C46C3B88AA8Q47204312-C76F7D50-5D32-4722-897C-68FEA5599D3CQ49843529-60884457-6E76-4EDA-8466-7A98B47F9955Q52609473-E038219A-6BE7-4AFB-932D-E835AEFFD2C7Q52615236-9B5199B6-AE0F-4639-A7AD-3DB98CB606DEQ53792928-E449B408-AE6B-4B33-A82E-D3DFAA73503DQ56343430-FC82F1C5-F0EF-43E8-9473-AD1D40657819Q56350341-9360F228-7CC2-49B8-9A26-AACF568AF446Q56363463-C8CE1FDD-B950-42E3-836D-E27D200A5386Q56376468-5BC13305-8EA9-4D11-90A6-89DE7281D6EFQ57945219-528A5C60-E435-4337-9252-2AD1944CEFB1Q58546525-F76A7ECB-B7DF-4710-865D-8C6B01B05004
P2860
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@ast
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@en
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@nl
type
label
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@ast
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@en
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@nl
prefLabel
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@ast
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@en
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@nl
P2093
P2860
P356
P1476
Efficacy of artemether-lumefan ...... re and Uíge Provinces, angola.
@en
P2093
Aleixo Panzo Macaia
Eldin Talundzic
Filomeno Fortes
Gail Stennies
Ira Goldman
John R MacArthur
Lindsay Morton
Mateusz M Plucinski
Naomi Lucchi
Pedro Rafael Dimbu
P2860
P304
P356
10.1128/AAC.04181-14
P407
P577
2014-11-03T00:00:00Z